Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample

被引:115
作者
Hall, Susan A.
Esche, Gretchen R.
Araujo, Andre B.
Travison, Thomas G.
Clark, Richard V. [1 ]
Williams, Rachel E. [1 ]
McKinlay, John B.
机构
[1] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1210/jc.2008-0021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Risk factors for low testosterone and symptomatic androgen deficiency (AD) may be modifiable. Objective: Our objective was to examine demographic, anthropometric, and medical correlates of low testosterone and symptomatic AD. Design: Data were used from the Boston Area Community Health Survey, an epidemiological study conducted from 2002-2005. Setting: Data were obtained from a community-based random sample of racially and ethnically diverse men. Patients or other Participants: Data were available for 1822 men. Main Outcome Measures: Multivariate logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations of covariates with 1) low testosterone and 2) symptomatic AD. The operational definition of low testosterone was serum total testosterone less than 300 ng/dl and free testosterone less than 5 ng/dl; symptomatic AD was defined as the additional presence of symptoms: any of low libido, erectile dysfunction, or osteoporosis or two or more of sleep disturbance, depressed mood, lethargy, or diminished physical performance. Results: Factors associated with low testosterone included age (OR = 1.36; 95% CI = 1.11-1.66, per decade), low per-capita income ($6000 or less per household member vs. more than $30,000; OR = 2.86; 95% CI = 1.39- 5.87), and waist circumference (per 10-cm increase; OR = 1.75; 95% CI = 1.45-2.12). Only age (OR = 1.36; 95% CI = 1.04-1.77), waist circumference (OR = 1.88; 95% CI = 1.44-2.47), and health status (OR = 0.21; 95% CI = 0.05-0.92, excellent vs. fair/poor) were associated with our construct of symptomatic AD. Of all variables, waist circumference was the most important contributor in both models. Conclusions: Waist circumference is a potentially modifiable risk factor for low testosterone and symptomatic AD. Manifestation of symptoms may be a consequence of generally poor health status.
引用
收藏
页码:3870 / 3877
页数:8
相关论文
共 41 条
[1]  
[Anonymous], 2004, SUDAAN LANG MAN REL
[2]   Prevalence of symptomatic androgen deficiency in men [J].
Araujo, Andre B. ;
Esche, Gretchen R. ;
Kupelian, Varant ;
O'Donnell, Amy B. ;
Travison, Thomas G. ;
Williams, Rachel E. ;
Clark, Richard V. ;
McKinlay, John B. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (11) :4241-4247
[3]   Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline [J].
Bhasin, Shalender ;
Cunningham, Glenn R. ;
Hayes, Frances J. ;
Matsumoto, Alvin M. ;
Snyder, Peter J. ;
Swerdloff, Ronald S. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) :1995-2010
[4]   Testosterone replacement therapy and prostate cancer: A word of caution [J].
Brand T.C. ;
Canby-Hagino E. ;
Thompson I.M. .
Current Urology Reports, 2007, 8 (3) :185-189
[5]  
Cochran WG., 1963, SAMPLING TECHNIQUES
[7]   Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska natives [J].
Espey, David K. ;
Wu, Xiao-Cheng ;
Swan, Judith ;
Wiggins, Charles ;
Jim, Melissa A. ;
Ward, Elizabeth ;
Wingo, Phyllis A. ;
Howe, Holly L. ;
Ries, Lynn A. G. ;
Miller, Barry A. ;
Jemal, Ahmedin ;
Ahmed, Faruque ;
Cobb, Nathaniel ;
Kaur, Judith S. ;
Edwards, Brenda K. .
CANCER, 2007, 110 (10) :2119-2152
[8]   Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study [J].
Feldman, HA ;
Longcope, C ;
Derby, CA ;
Johannes, CB ;
Araujo, AB ;
Coviello, AD ;
Bremner, WJ ;
McKinlay, JB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :589-598
[9]  
Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041
[10]   Trends and regional differences in testosterone prescribing in Australia, 1991-2001 [J].
Handelsman, DJ .
MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (08) :419-422